occurr
influenza
pandem
worldwid
phenomenon
signific
caus
mortal
morbid
throughout
globe
due
mutat
influenza
viru
genet
materi
creat
antigen
drift
pathogen
viral
protein
result
emerg
new
influenza
viru
strain
therefor
vaccin
avail
prevent
influenza
offer
protect
influenza
pandem
caus
new
viru
strain
moreov
exist
drug
use
combat
influenza
may
ineffect
treat
influenza
pandem
due
emerg
drug
resist
pandem
viru
strain
therefor
work
strategi
must
develop
combat
influenza
pandem
review
address
problem
review
publish
studi
ascorb
acid
common
cold
influenza
laboratori
studi
effect
ascorb
acid
influenza
viru
also
correl
clinic
laboratori
studi
develop
hypothesi
prevent
influenza
pandem
common
cold
acut
viral
nasopharyng
mild
selflimit
infecti
diseas
caus
differ
virus
rhinoviru
coronaviru
respons
approxim
common
cold
contrast
influenza
acut
respiratori
ill
caus
primarili
influenza
viru
serotyp
b
occur
worldwid
respons
consider
morbid
mortal
influenza
usual
sever
common
cold
typic
caus
fever
headach
muscl
ach
signific
cough
howev
mild
case
influenza
similar
cold
two
serotyp
influenza
occur
frequent
danger
virus
caus
common
cold
gener
inhal
attach
protein
intercellular
adhes
get
nasal
epithelium
caus
inflammatori
respons
insid
cell
viru
prolifer
host
cell
ruptur
virus
avail
occupi
fresh
intercellular
adhes
receptor
influenza
virus
typic
divid
two
gener
subtyp
correspond
two
differ
antigen
surfac
viru
hemagglutinin
neuramidas
hemagglutinin
antigen
h
glycoprotein
allow
viru
bind
respiratori
epitheli
cell
membran
sialic
acid
fuse
host
cell
membran
incorpor
host
cell
viral
rna
integr
host
cell
genom
start
form
new
virion
particl
transport
host
cell
membran
viral
neuramidas
antigen
n
break
sialic
acid
allow
viru
dispers
infect
cell
mutat
occur
influenza
virus
result
frequent
emerg
new
viral
strain
antigen
drift
immunolog
differ
h
n
antigen
exampl
observ
avian
influenza
viral
strain
recent
pandem
swine
flue
influenza
viru
strain
known
caus
influenza
pandem
consequ
antibodi
rais
known
influenza
viru
strain
vaccin
program
prevent
diseas
caus
emerg
new
viral
strain
needless
mention
vaccin
develop
combat
new
strain
influenza
viru
possibl
nation
within
short
time
control
influenza
pandem
emerg
therefor
altern
strategi
combat
influenza
pandem
urgent
necessari
success
control
pandem
review
address
problem
develop
hypothesi
may
pave
path
combat
influenza
pandem
clinic
experi
vitamin
c
manag
influenzacommon
cold
consider
interest
regard
associ
vitamin
c
ascorb
acid
common
cold
sinc
claim
famou
scientist
linu
paul
ascorb
acid
physiolog
effect
common
cold
megados
vitamin
c
gd
shown
prevent
cold
flu
symptom
student
age
lower
dose
vitamin
c
shown
prevent
cold
symptom
number
trial
dose
vitamin
c
excess
gd
taken
shortli
onset
cold
symptom
decreas
durat
sever
cold
symptom
healthi
adult
volunt
compar
vitamin
c
dose
lower
minimum
recommend
daili
intak
case
confirm
influenza
rel
clinic
trial
examin
efficaci
vitamin
c
control
trial
patient
influenza
patient
receiv
vitamin
c
mgd
patient
serv
control
outcom
measur
develop
pneumonia
durat
hospit
stay
pneumonia
report
two
subject
treatment
group
control
group
hospit
stay
influenza
relat
complic
averag
vitamin
c
group
control
group
mani
review
provid
metaanalys
matter
conclud
correl
vitamin
c
supplement
incid
cold
symptom
gener
popul
also
persist
view
challeng
conclus
fact
widespread
percept
conclus
associ
vitamin
c
supplement
cold
symptom
mostli
due
inaccur
review
methodolog
vitro
cell
cultur
system
ascorb
acid
shown
exhibit
specif
antivir
effect
influenza
viru
vero
cell
line
show
inhibit
influenza
viral
prolifer
mm
h
mdck
cell
line
specif
antivir
effect
ascorb
acid
observ
higher
dose
mm
dosedepend
manner
ascorb
acid
mm
shown
inhibit
cell
cycl
fibroblast
vitro
cell
cultur
system
phase
inhibit
entri
cell
phase
probabl
downmodul
gene
essenti
sphase
progress
ascorb
acidinduc
inhibit
cell
enter
phase
cell
cycl
may
inhibit
integr
viral
genet
materi
host
genom
case
rna
virus
incorpor
viral
genet
materi
host
cell
genom
host
cell
cycl
must
arrest
phase
regard
influenza
viru
corona
viru
picorna
viru
except
rna
virus
moreov
ascorb
acid
shown
stimul
lxra
gene
express
known
caus
downregul
cmyc
gene
downregul
cmyc
gene
arrest
cell
cycl
phase
result
restrict
entri
cell
phase
reduc
number
cell
phase
viral
genom
integr
also
proven
fact
ascorb
acid
inhibit
viral
replic
rna
virus
human
immunodefici
viru
avian
tumor
viru
ascorb
acid
also
observ
exhibit
sustain
antivir
effect
influenza
viru
presenc
iron
may
due
prooxid
effect
vitamin
c
dehydroascorb
shown
effect
significantli
compar
ascorb
vivo
ascorb
acid
observ
play
prooxid
role
observ
critic
exhibit
prooxid
effect
bronchial
epithelium
avail
iron
oxid
hydrogen
peroxid
limit
factor
local
avail
ascorb
acid
iron
hydrogen
peroxid
present
vicin
bronchial
epithelium
influenza
viru
infect
known
produc
matrix
metalloproteas
mmp
epitheli
cell
thought
mechan
spread
viru
vero
cell
infect
influenza
viru
shown
produc
substanti
clinic
case
influenza
enceph
also
prove
significantli
serum
concentr
ascorb
acid
shown
reduc
gene
express
peripher
bloodderiv
mononuclear
cell
also
shown
decreas
synthesi
induc
hydrogen
peroxid
vitro
chorioamniot
membran
model
well
known
mmp
import
cancer
metastasi
vitamin
c
prove
inhibit
migrat
cancer
cell
independ
antioxid
activ
therefor
like
avail
vitamin
c
respiratori
epithelium
inhibit
possibl
lethal
mediat
inflamm
reduc
extent
harm
due
influenza
viru
infect
support
view
studi
anim
model
system
demonstr
enhanc
lung
patholog
influenza
virusinfect
vitamin
cdefici
mous
model
experiment
evid
indic
vitamin
cinduc
inhibit
influenza
viru
prolifer
repres
figur
laboratori
report
state
antivir
effect
ascorb
acid
influenza
viru
challeng
report
thu
far
antivir
activ
ascorb
acid
influenza
viru
due
interact
h
n
antigen
viru
may
due
prooxid
effect
genom
effect
cell
cycl
arrest
phase
perhap
therefor
antivir
activ
ascorb
acid
occur
irrespect
antigen
drift
viru
chang
n
h
antigen
caus
influenza
pandem
emerg
render
exist
influenza
vaccin
ineffect
prevent
pandem
influenza
viru
strain
infect
caus
drug
resist
neuraminidas
inhibitor
n
commun
although
mani
trial
assess
relat
cold
flu
symptom
vitamin
c
supplement
trial
assess
specif
viral
load
influenza
epidemicpandem
popul
ascorb
acid
supplement
supplement
trial
review
sever
time
individu
studi
consid
trial
mostli
estim
viral
load
ascorb
acid
concentr
avail
respiratori
secret
vitamin
c
supplement
therefor
avail
review
metaanalys
speak
vitamin
c
supplement
may
exist
without
substanti
error
avail
ascorb
acid
bronchial
secret
proven
fact
shown
supplement
vitamin
c
ascorb
acid
concentr
bronchial
secret
around
mm
concentr
ineffect
exhibit
antivir
effect
mdck
cell
line
arrest
cell
cycl
phase
fibroblast
therefor
opinion
sustain
high
dose
vitamin
c
avail
respiratori
secret
exhibit
substanti
anti
influenza
viru
activ
oral
megados
ascorb
acid
normal
popul
advis
report
caus
diarrhea
normal
individu
conclus
studi
report
oral
high
dose
ascorb
acid
deliv
suffici
amount
ascorb
acid
bronchial
secret
explor
antitumor
activ
ascorb
acid
intraven
rout
propos
analog
achiev
high
concentr
ascorb
acid
bronchial
epithelium
propos
ascorb
acid
supplement
inhal
rout
recent
time
steroid
inhal
routin
use
asthmat
patient
technolog
develop
ascorb
acid
deliveri
system
inhal
rout
expect
develop
quickli
without
much
difficulti
addit
ascorb
acid
supplement
inhal
rout
oral
suppli
ascorb
acid
combin
oral
ascorb
acid
supplement
known
enhanc
iron
absorpt
gastrointestin
tract
may
respons
kill
influenza
viru
presenc
ascorb
acid
bronchial
epithelium
everi
reason
believ
combin
mode
ascorb
acid
supplement
may
render
host
resist
influenza
viru
infect
even
newli
emerg
pandem
strain
start
trial
directli
human
preclin
studi
anim
model
must
conduct
determin
possibl
toxic
approach
preclin
studi
show
encourag
result
appropri
clinic
trial
design
avail
ascorb
acid
concentr
bronchial
secret
viral
load
must
correl
interpret
outcom
adequ
monitor
trial
harm
combin
approach
ascorb
acid
supplement
correl
avail
ascorb
acid
bronchial
epithelium
viral
load
conclus
decid
widespread
anticip
ascorb
acid
prevent
measur
influenza
right
wrong
influenza
viru
infect
respiratori
tract
epitheli
cell
frequent
caus
flu
pandem
emerg
due
emerg
new
strain
viru
possibl
antigen
shift
drift
viral
protein
render
diseas
unprevent
vaccin
host
known
influenza
viral
strain
vitamin
c
long
expect
offer
protect
influenza
clinic
studi
conduct
thu
far
fail
provid
unbias
conclus
matter
contradictori
view
topic
report
convers
laboratori
studi
show
promis
antivir
effect
vitamin
c
multipl
way
higher
concentr
unlik
attain
respiratori
tract
epithelium
oral
supplement
vitamin
c
therefor
combin
oral
inhal
rout
vitamin
c
deliveri
provid
higher
concentr
vitamin
c
respiratori
epithelium
site
influenza
viru
infect
possibl
impart
antiinfluenza
viru
immun
irrespect
infect
caus
new
old
viru
strain
approach
work
propos
name
paul
vaccin
would
tribut
linu
paul
strongli
believ
vitamin
c
supplement
could
protect
mankind
cold
flu
